search
Back to results

Modeling Impaired Judgement in Cocaine Abusers - 6

Primary Purpose

Cocaine-Related Disorders, Substance-Related Disorders

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Amantadine
Sponsored by
National Institute on Drug Abuse (NIDA)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cocaine-Related Disorders

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: (3 groups)Normal, healthy controls. Recent cocaine experience. Over 6 months since the last cocaine experience. Exclusion Criteria: Psychosis or mood disorder. History of seizure, head trauma

Sites / Locations

  • New York MDRU

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
April 18, 2001
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
New York MDRU
search

1. Study Identification

Unique Protocol Identification Number
NCT00015236
Brief Title
Modeling Impaired Judgement in Cocaine Abusers - 6
Official Title
Modeling Impaired Judgement in Cocaine Abusers
Study Type
Interventional

2. Study Status

Record Verification Date
June 1998
Overall Recruitment Status
Completed
Study Start Date
March 1997 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
New York MDRU

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is for the modeling of impaired judgement in cocaine abusers.
Detailed Description
The objective of this study is to investigate recognition memory and appreciation of changing contingencies in relation to a response judgement.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders, Substance-Related Disorders

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Masking
None (Open Label)
Enrollment
0 (false)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Amantadine

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: (3 groups)Normal, healthy controls. Recent cocaine experience. Over 6 months since the last cocaine experience. Exclusion Criteria: Psychosis or mood disorder. History of seizure, head trauma
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Rotrosen, M.D.
Organizational Affiliation
New York MDRU
Official's Role
Principal Investigator
Facility Information:
Facility Name
New York MDRU
City
New York
State/Province
New York
ZIP/Postal Code
10010
Country
United States

12. IPD Sharing Statement

Citations:
Citation
NIDA Research Monograph Series 179, 1998 CPDD 98, 99.
Results Reference
background

Learn more about this trial

Modeling Impaired Judgement in Cocaine Abusers - 6

We'll reach out to this number within 24 hrs